Grace L. Wirth is a counsel in Goodwin’s ERISA & Executive Compensation practice and represents a wide variety of clients, including both public and private companies at all stages of the corporate lifecycle, boards of directors and compensation committees, venture capital and private equity funds and members of management, with a focus on emerging growth companies in the technology and life sciences sector. Ms. Wirth advises on all aspects of executive and employee compensation, as well as on tax and securities law issues in connection with equity-based arrangements and other types of incentive plans.

Ms. Wirth works closely with clients on compensation issues that arise in connection with mergers and acquisitions, financings, initial public offerings and other corporate transactions. In addition, she regularly advises both employers and executives in the negotiation, design and implementation of employment, severance, change in control and equity arrangements. Ms. Wirth also counsels clients regarding compliance with tax rules relating to deferred compensation, tax planning with respect to the excise tax on excess parachute payments, limits on the deductibility of executive compensation and SEC rules governing executive compensation disclosure and reporting.

Areas of Practice
业务范围
Domaines D’Expertise
TÄTIGKEITSFELDER

Experience

工作经历

EXPÉRIENCE

ERFAHRUNG

Representative Matters

代表事项

REFERENZMANDATE

Public Offerings
  • Companies, such as Toast, Graphite Bio, AbCellera Biologics, Pliant Therapeutics, Health Catalyst, BridgeBio Pharma, Moderna, Eidos Pharmaceuticals, Twilio, Atlassian, Amplify Snack Brands, TPI Composites, ClubCorp Holdings* and Orchard Supply Hardware*, on their initial public offerings as well as follow-on offerings.
  • Investment banks, such as Goldman Sachs, Morgan Stanley, and JP Morgan, on the initial public offerings of Femasys, Rani Therapeutics, Immunome, Root Insurance, Blue Apron, MuleSoft, Fitbit, Penumbra, Tintri, Intermedia, Talend, Facebook*, Realogy*, Bright Horizons Family Solutions*, Vince Holdings*, Tesla*, RealPage* and Neophotonics*.
Spac Ipos And Despac Transactions
  • Circle Internet Financial on its definitive business combination with Concord Acquisition Corp.
  • Pardes Bio on its definitive business combination with FS Development Corp. II
  • Clarus Therapeutics on its definitive business combination with Blue Water Acquisition Corp.
  • Better Therapeutics on its definitive business combination with Mountain Crest Acquisition Corp. II
  • Rocket Lab on its definitive business combination with Vector Acquisition Corp.
M&A – Executive Compensation
  • Retail Properties of America in its strategic merger with Kite Realty Group Trust for $7.5 billion
  • MyoKardia in its sale to Bristol Myers Squibb for $13.1 billion
  • Zoox in its sale to Amazon
  • Vlocity in its sale to Salesforce for over $1.5 billion
  • Carbon Black in its sale to VMware for $2.1 billion
  • Control4 in its sale to SnapAV for $680 million
  • Spark Therapeutics in its sale to Roche for $4 billion
  • Centerbridge Partners in its acquisition of Civitas Solutions for $1.4 billion
  • AppNexus in its sale to AT&T
  • OLLY PBC in its sale to Unilever PLC
  • Index in its sale to Stripe
  • Amplify Snack Brands in its sale to Hershey for $1.6 billion and Amplify Snack Brands in its acquisition of Tyrrells
  • Chariot in its sale to Ford
  • Xoom in its sale to PayPal for $890 million
  • Blueprint Medicines, AbCellera Biologics, Amplitude, Hopin, Health Catalyst, Atlassian, Fitbit, Guidewire and Twilio in several acquisitions, including Twilio’s acquisition of SendGrid for $3 billion
  • Teva Pharmaceuticals in its acquisition of Auspex Pharmaceuticals for $3.2 billion
  • TellApart in its sale to Twitter for $533 million
  • Trulia in its sale to Zillow for $3.5 billion
  • Thoma Bravo in its acquisition of iPipeline and Infogix and various other acquisitions
  • Silver Lake Partners in its acquisition of Dell for $24.4 billion, acquisition of Interactive Data Corporation for $3.4 billion and various other acquisitions and sales*
  • Hellman & Friedman in its acquisition of Associated Materials for $1.3 billion, sale of Vertafore to TPG Capital for $1.4 billion and various other acquisitions and sales*
Ongoing Representation
  • Public companies: Toast, Rocket Lab, Affirm, Amplitude, Clarus Therapeutics, Better Therapeutics, Pardes Bio, Graphite Bio, AbCellera Biologics, Pliant Therapeutics, Nektar Therapeutics, BridgeBio Pharma, Moderna, Atlassian, TPI Composites, Blueprint Medicines, Fate Therapeutics, Global Blood Therapeutics and Guidewire Software
  • Private companies: Freedom Financial Network, Miro, Rubrik and Videoamp.

*Denotes experience prior to joining Goodwin.

Professional Experience

Prior to joining Goodwin, Ms. Wirth practiced at Simpson Thacher & Bartlett. Earlier in her career, Ms. Wirth was an associate consultant in the Health & Welfare Benefits group at Tower Perrin (now known as Willis Towers Watson).

In The News

相关新闻

ACTUALITÉS

MELDUNGEN

Credentials

专业资格

RÉFÉRENCES

WERDEGANG

Education

J.D.
Georgetown University Law Center
B.A.
Stanford University

Admissions

Bar

California
District of Columbia
Profile Image
Get In Touch
联系我们
NOUS CONTACTER
Kontakt
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Search Other Lawyers
搜寻其他律师
Recherche par Pratique
ANWALTSSUCHE